Int J Stomatol

Int J Stomatol ›› 2019, Vol. 46 ›› Issue (6): 631-639.doi: 10.7518/gjkq.2019096

• Orginal Articles • Previous Articles     Next Articles

Expression of zinc finger protein 32 in oral squamous cell carcinoma and its effect on oral squamous cell carcinoma stem cells

Chen Hongli1,Yang Jing2,Yin Gang2,Li Haoyuan3,Qiao Yan4()   

  1. 1. Dept. of Stomatology and Teaching Research, Fenyang College of Shanxi Medical University, Fenyang 032000, China
    2. Dept. of Stomatology, Fenyang Hospital Affiliated to Shanxi Medical University, Fenyang 032200, China
    3. School of Stomatology, Shanxi Medical University, Taiyuan 030001, China
    4. Dept. of Stomatology, South Hospital of Tongchuan People’s Hospital, Tongchuan 727031, China;
  • Received:2019-01-26 Revised:2019-07-26 Online:2019-11-01 Published:2019-11-14
  • Contact: Yan Qiao E-mail:2335878508@qq.com
  • Supported by:
    This study was supported by Shanxi Health Family Planning Research Project(20150183)

RichHTML

20

PDF (PC)

488

Abstract: Objective To investigate the expression of zinc finger protein 32 (ZNF32) in oral squamous cell carcinoma (OSCC) and the relationship between the expression of ZNF32 in OSCC and the clinical features, and to explore the effect of ZNF32 on OSCC cancer stem cells (CSCs).Methods Quantitative real time polymerase chain reaction (qRT-PCR) was used to detect the expression of ZNF32 mRNA in 45 OSCC tissues and 15 normal oral mucosa tissues. The relationship between the expression of ZNF32 in OSCC tissues and clinical features was analyzed. Magnetic beads were used to sort CSCs in the OSCC cell line Cal-27. Western-blot was used to detect the expression of organic cation/carnitine transporter 4 (OCT4), Nanog homeobox (Nanog), sex determining region Y-box2 (SOX2) stem marker protein and ZNF32 in CSCs. After transfected with ZNF32 siRNA (si-ZNF32) and control (si-NC) for 48 h,3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) was used to detect the proliferation, plate clones were used to detect the ability of CSCs to form clones. Transwell assay was used to detect the metastasis ability of CSCs. Western-blot was used to detect the expression of signal transducer and activator of transcription 3 (STAT3) and phosphorylated signal transducer and activator of transcription 3 (pSTAT3) proteins in CSCs.Results The expression of ZNF32 mRNA in OSCC tissues was significantly higher than that in normal oral mucosa. The high expression of ZNF32 mRNA was significantly correlated with OSCC tumor low differentiation, advance TNM stage and lymph node metastasis (P<0.05). The expression of OCT4, Nanog and SOX2 stem marker proteins was significantly increased in CSCs. The expression of ZNF32 in CSCs was significantly higher than that in OSCC cells Cal-27 and human oral keratinocyte (P<0.05). After transfection with ZNF32 siRNA, the cell proliferation, plate clone formation and metastasis ability of CSCs decreased, and the expression of pSTAT3 protein in CSCs cells decreased (P<0.05).Conclusion ZNF32 is highly expressed in OSCC tissues and cell lines, and high expression is associated with low tumor differentiation, advanced TNM stage and lymph node metastasis. Interfering with the expression of ZNF32 and inhibits the biological characteristics of OSCC CSCs. ZNF32 can be used as a potential treatment molecular targets for OSCC.

Key words: oral squamous cell carcinoma, zinc finger protein 32, cancer stem cell, signal transducer and activator of transcription 3

CLC Number: 

  • R739.85

TrendMD: 

Fig 1

The expression of ZNF32 mRNA in OSCC tissues detected by qRT-PCR"

Tab 1

Relationship between expression of ZNF32 mRNA in OSCC tissues and clinical case characteristics"

临床病例特征 例数 ZNF32 mRNA相对表达量 t值 P值
性别 男 28 1.30±0.25 1.327 0.545
女 17 1.17±0.18
年龄/岁 <55 15 1.23±0.24 0.984 0.084
≥55 30 1.27±0.20
肿瘤大小/cm <4 36 1.20±0.50 3.048 0.061
≥4 9 1.45±0.33
组织学分级 高分化 26 1.06±0.40 3.445 0.001
低分化 19 1.50±0.46
TNM分期 Ⅰ~Ⅱ 23 1.02±0.36 3.613 0.000
Ⅲ~Ⅳ 22 1.49±0.48
淋巴结转移 无 23 1.01±0.30 3.869 0.000
有 22 1.50±0.51

Fig 2

The expression of OCT4, Nanog and SOX2 stem marker proteinsdetected by Western-blot"

Fig 3

The expression of ZNF32 protein in OSCC CSCs detected byWestern-blot"

Fig 4

The effect of ZNF32 on the proliferation of CSCs detected byMTS"

Fig 5

The effect of ZNF32 on the colony ability of CSCs detected byclone formation assay inverted microscope × 100"

Fig 6

The effect of ZNF32 on the metastasis ability of CSCs detectedby transwell assay inverted microscope × 100"

Fig 7

The effect of ZNF32 on the STAT3 signaling pathway detectedby Western-blot"

[1] Li YY, Xu ZM, Li J , et al. Interleukin-18 expression in oral squamous cell carcinoma: its role in tumor cell migration and invasion, and growth of tumor cell xenografts[J]. FEBS Open Bio, 2018,8(12):1953-1963.
[2] Omura K . Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma[J]. Int J Clin Oncol, 2014,19(3):423-430.
[3] Shimomura H, Sasahira T, Nakashima C , et al. Down-regulation of DHRS9 is associated with poor pro-gnosis in oral squamous cell carcinoma[J]. Pathology, 2018,50(6):642-647.
[4] Kansy K, Mueller AA, Mücke T , et al. A worldwide comparison of the management of surgical treatment of advanced oral cancer[J]. J Craniomaxillofac Surg, 2018,46(3):511-520.
[5] Brennan PA, Subramaniam S, Tsioryannis C , et al. An update on the latest evidence for managing the clinically negative neck (cN0) in oral squamous cell carcinoma[J]. Oral Dis, 2017,23(3):287-291.
[6] Ortiz RC, Lopes NM, Amôr NG , et al. CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma[J]. J Oral Pathol Med, 2018,47(8):740-747.
[7] Kerk SA, Finkel KA, Pearson AT , et al. 5T4-targeted therapy ablates cancer stem cells and prevents recur-rence of head and neck squamous cell carcinoma[J]. Clin Cancer Res, 2017,23(10):2516-2527.
[8] Chen DM, Wu MS, Li Y , et al. Targeting BMI1 + cancer stem cells overcomes chemoresistance and inhibits metastases in squamous cell carcinoma[J]. Cell Stem Cell, 2017, 20(5): 621-634.e6.
[9] Johansson AC, La Fleur L, Melissaridou S , et al. The relationship between EMT, CD44 high/EGFR low pheno-type, and treatment response in head and neck cancer cell lines [J]. J Oral Pathol Med, 2016,45(9):640-646.
[10] Rhost S, Hughes É, Harrison H , et al. Sortilin inhi-bition limits secretion-induced progranulin-dependent breast cancer progression and cancer stem cell ex-pansion[J]. Breast Cancer Res, 2018,20(1):137.
[11] Li YC, Xu FM, Zhang GQ , et al. Down-regulation of microRNA-21 inhibits cell proliferation and invasion of high-invasion liver cancer stem cells[J]. Eur Rev Med Pharmacol Sci, 2018,22(22):7832-7840.
[12] Makena MR, Ranjan A, Thirumala V , et al. Cancer stem cells: road to therapeutic resistance and strate-gies to overcome resistance[J]. Biochim Biophys Acta Mol Basis Dis, 2018. doi: 10.1016/j.bbadis.2018.11.015.
[13] Cannizzaro LA, Aronson MM, Thiesen HJ . Human zinc finger gene ZNF23 (Kox16) maps to a zinc finger gene cluster on chromosome 16q22, and ZNF32 (Kox30) to chromosome region 10q23-q24[J]. Hum Genet, 1993,91(4):383-385.
[14] Li J, Ao J, Li K , et al. ZNF32 contributes to the in-duction of multidrug resistance by regulating TGF-β receptor 2 signaling in lung adenocarcinoma[J]. Cell Death Dis, 2016,7(10):e2428.
[15] Li K, Gao B, Li J , et al. ZNF32 protects against oxidative stress-induced apoptosis by modulating C1QBP transcription[J]. Oncotarget, 2015,6(35):38107-38126.
[16] Li YY, Gong D, Zhang L , et al. Zinc finger protein 32 promotes breast cancer stem cell-like properties through directly promoting GPER transcription[J]. Cell Death Dis, 2018,9(12):1162.
[17] Gu W, Yeo E, McMillan N, et al. Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability[J]. Cancer Gene Ther, 2011,18(12):897-905.
[18] Siegel RL, Miller KD, Jemal A . Cancer statistics, 2018[J]. CA Cancer J Clin, 2018,68(1):7-30.
[19] 王倩, 侯大为 . 口腔鳞状细胞癌发病及转移机制研究进展[J]. 口腔医学研究, 2018,34(11):1164-1167.
Wang Q, Hou DW . Research progress in pathogenesis of oral squamous cell carcinoma[J]. J Oral Sci Res, 2018,34(11):1164-1167.
[20] Haranadh S, Nandyala R, Bodagala V , et al. A pros-pective analysis of prevalence of metastasis in levels ⅡB and Ⅴ neck nodes in patients with operable oral squamous cell carcinoma[J]. Oral Oncol, 2018,83:115-119.
[21] Ettinger KS, Ganry L, Fernandes RP . Oral cavity cancer[J]. Oral Maxillofac Surg Clin North Am, 2019,31(1):13-29.
[22] Chen L, Li YC, Wu L , et al. TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma[J]. J Cell Mol Med, 2018,22(2):1337-1349.
[23] Rodrigues MFSD, Miguita L, De Andrade NP , et al. GLI3 knockdown decreases stemness, cell proli-feration and invasion in oral squamous cell carcinoma[J]. Int J Oncol, 2018,53(6):2458-2472.
[24] Wei YY, Li K, Yao SH , et al. Loss of ZNF32 augments the regeneration of nervous lateral line system through negative regulation of SOX2 transcription[J]. Oncotarget, 2016,7(43):70420-70436.
[25] Li K, Zhao G, Ao J , et al. ZNF32 induces anoikis resistance through maintaining redox homeostasis and activating Src/FAK signaling in hepatocellular carcinoma[J]. Cancer Lett, 2019,442:271-278.
[26] Li YY, Zhang L, Li K , et al. ZNF32 inhibits auto-phagy through the mTOR pathway and protects MCF-7 cells from stimulus-induced cell death[J]. Sci Rep, 2015,5:9288.
[27] 尹彦斌, 王建杰, 刘祎 , 等. 肿瘤干细胞分离研究进展[J]. 现代生物医学进展, 2016,16(2):382-385.
Yin YB, Wang JJ, Liu Y , et al. Progress in isolation of cancer stem cells[J]. Prog Mod Biomed, 2016,16(2):382-385.
[28] 俞晓毓, 吴迪, 王净 , 等. 卵巢癌细胞系ID8中肿瘤干细胞的分离及生物学特性鉴定[J]. 中国组织工程研究, 2018,22(29):4687-4691.
Yu XY, Wu D, Wang J , et al. Isolation and biological identification of tumor stem cells from ovarian cancer ID8 cell lines[J]. Chin J Tissue Eng Res, 2018,22(29):4687-4691.
[29] de Moraes FP, Lourenço SV, Ianez RC , et al. Expre-ssion of stem cell markers in oral cavity and oro-pharynx squamous cell carcinoma[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2017,123(1):113-122.
[30] Kaseb HO, Fohrer-Ting H, Lewis DW , et al. Identi-fication, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas[J]. Exp Cell Res, 2016,348(1):75-86.
[31] Zhang ZL, Han H, Rong YP , et al. Hypoxia poten-tiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling[J]. J Exp Clin Cancer Res, 2018,37(1):291.
[32] Qin T, Li B, Feng XY , et al. Abnormally elevated USP37 expression in breast cancer stem cells re-gulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity[J]. J Exp Clin Cancer Res, 2018,37(1):287.
[33] 赵晓晚, 范凯华, 李中悦 , 等. STAT3和EMT与肿瘤的关系[J]. 甘肃医药, 2018,37(9):779-781.
Zhao XW, Fan KH, Li ZY , et al. The relationship between STAT3, EMT and tumor[J]. Gansu Med J, 2018,37(9):779-781.
[34] Tong MT, Wang J, Jiang NN , et al. Correlation between p-STAT3 overexpression and prognosis in lung cancer: a systematic review and meta-analysis[J]. PLoS One, 2017,12(8):e0182282.
[35] 朱正春, 姚梦群, 严芳莉 , 等. 西黄丸对肝癌HepG2细胞增殖、侵袭及STAT3信号通路的影响[J]. 安徽医科大学学报, 2018,53(12):1875-1878.
Zhu ZC, Yao MQ, Yan FL , et al. Effects of Xihuang pill on proliferation and invasion of HepG2 cells and STAT3 signal pathway[J]. Acta Univ Med Anhui, 2018,53(12):1875-1878.
[36] Rios-Fuller TJ, Ortiz-Soto G, Lacourt-Ventura M , et al. Ganoderma lucidum extract (GLE) impairs breast cancer stem cells by targeting the STAT3 pathway[J]. Oncotarget, 2018,9(89):35907-35921.
[1] Zhou Jinkuo,Zhang Jinhong,Shi Xiaojing,Liu Guangshun,Jiang Lei,Liu Qianfeng. Influences of long noncoding RNA small nucleolar RNA host gene 22 on the cell proliferation, invasion and migration of oral squamous carcinoma cells by regulating microRNA-27b-3p [J]. Int J Stomatol, 2024, 51(1): 52-59.
[2] Li Liheng,Wang Rui,Wang Xiaoming,Zhang Zhiyi,Zhang Xuan,An Feng,Wang Qin,Zhang Fan. Effects of circular RNA hsa_circ_0085576 on cell migration and invasion of oral squamous cell carcinoma by regulating the microRNA-498/B-cell-specific Moloney murine leukemia virus integration site 1 axis [J]. Int J Stomatol, 2024, 51(1): 60-67.
[3] Wu Jiamin,Xia Bin,Yang Hefeng,Xu Biao.. Research progress on cancer-associated fibroblasts in the tumor microenvironment of oral squamous cell carcinoma [J]. Int J Stomatol, 2023, 50(6): 711-717.
[4] Liu Jianglong, Tuerdi Maimaitituxun. Progress of contrast-enhanced ultrasound in the diagnosis of cervical lymph node metastasis from oral squamous cell carcinoma [J]. Int J Stomatol, 2023, 50(5): 514-520.
[5] Sheng Nanning,Wang Jue,Nan Xinrong. Research progress on mechanism and treatment of sex-determining region Y box 9 in oral squamous cell carcinoma [J]. Int J Stomatol, 2023, 50(3): 314-320.
[6] Li Tan,Liang Xin-hua.. Role of discoidin domain receptor 1 in the regulation of malignant tumor progression and therapy [J]. Int J Stomatol, 2023, 50(2): 230-236.
[7] Zhao Zhuoping,Xin Pengfei,Gao Yang,Zhang Caifeng,Zhang Kuanshou,Liu Qingmei. Research progress on the use of photothermal therapy to treat oral squamous cell carcinoma [J]. Int J Stomatol, 2022, 49(4): 462-470.
[8] Jiang Han,Shen Yingqiang,Chen Qianming. Experimental study of muscarinic receptors on the biological behavior of oral squamous cell carcinoma through Yes related protein signal [J]. Int J Stomatol, 2022, 49(2): 138-143.
[9] Jiang Yulei,Xia Bin,Rao Nanquan,Yang Hefeng,Xu Biao. Exosomes mediate the malignant progression of oral squamous cell carcinoma and its application in diagnosis and treatment [J]. Int J Stomatol, 2021, 48(6): 711-717.
[10] Gan Jianguo,Gao Pan,Wang Xiaoyi. Research progress on the relationship between circulating tumor cells and oral squamous cell carcinoma [J]. Int J Stomatol, 2021, 48(2): 205-212.
[11] Huang Junwen,Qiao Jie,Mei Zi,Chen Zhuo,Li Yang,Qiao Bin. Expression and clinical significance of lipopolysaccharide binding protein in oral squamous cell carcinoma [J]. Int J Stomatol, 2021, 48(1): 50-57.
[12] He Yuqing,Dan Hongxia,Chen Qianming. Application of photodynamic therapy for oral carcinogenesis prevention [J]. Int J Stomatol, 2020, 47(6): 669-676.
[13] Hao Fu,Ning Yi,Sun Rui,Zheng Xiaoxu. Expression and potential clinical significance of Transformer 2β in oral squamous cell carcinoma [J]. Int J Stomatol, 2020, 47(2): 159-165.
[14] Xue Lingli,Li Yadong. Survival analysis of patients with oral squamous cell carcinoma treated by radical surgery for the first time [J]. Int J Stomatol, 2020, 47(2): 166-174.
[15] Bing Yan,Xianyang Luo,Yingyun Tan,Limei Guan,Lili Xue. Research on the surface-enhanced Raman spectrum of blood serum for clinical staging of oral squamous cell carcinoma [J]. Int J Stomatol, 2019, 46(3): 277-281.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[2] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[3] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[4] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[5] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[6] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[7] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[8] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[9] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[10] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .